U.S.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549
FORM
8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (date of earliest event reported): June 1, 2010
Medisafe
1 Technologies Corp.
(Exact
name of registrant as specified in its charter)
Delaware
(State or
other jurisdiction of incorporation)
| 333-161914 | 46-0523031 | ||
|
(Commission
File No.)
|
(IRS Employer
Identification No.)
|
c/o Jacob
Elhadad
5A
Hataltan Street
Jerusalem
, Israel 96926
Phone
Number 972-77-3318877
Fax
number 972-77-3318879
(Address
and telephone number of principal executive offices and place of
business)
(former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below)
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13ed-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Section
8– Other Events
Item
8.01 Other Events
On June
1, 2010, Medisafe 1 Technologies Corp. (the “Registrant”) concluded and
terminated its public offering held in accordance with the Registration
Statement on Form S-1, which was declared effective by the Securities and
Exchange Commission on March 11, 2010. The Registrant sold all
4,000,000 shares offered for a purchase price of $0.025 per share, amounting in
the aggregate to $100,000.00. The Registrant now has a total of
10,000,000,000 shares issued and outstanding.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934 the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated:
June 14, 2010
|
Medisafe
1 Technologies Corp.
By: Jacob Elhadad
Jacob
Elhadad
Title:
President and Director
(Principal
Executive Officer)
|